Learn from our experts how ITC and GCI are complementary and orthogonal techniques for all your early-stage drug discovery needs. Discover how ITC and GCI technologies can be applied to complex targets and interactions in a series of applications from hit identification to lead-optimization.
Présentateur
- Edward Fitzgerald - Segment Lead - Drug Discovery, Malvern Panalytical
- Marta Janczuk-Richter - Application Scientist, Malvern Panalytical
- Stoyan Milev - Applications Specialist, Malvern Panalytical
Pour en savoir plus
Who should attend?
- Scientists and researchers interested in small molecule/fragment screening using state-of-the-art biophysics
- Anyone interested in or working in Drug Discovery
What will you learn?
- Hit finding: How to establish a fragment screen using GCI
- Hit identification: Tips, tricks and considerations
- Hit validation: How to orthogonally validate hits using ITC
- Tips, tricks and considerations in going from hit to lead (H2L)